Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / HypoxyStat
Entity

HypoxyStat

Tracked across 1 events · 21 articles · First seen Feb 19, 2026 · Last active Feb 24, 2026

Sentiment
80
Attention
4
Events
1
Relationships
7
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 80
Tech
Red Blood Cells Act as Glucose Sponges
HypoxyStat is a drug developed in Isha Jain's lab that mimics the effects of low-oxygen air. It completely reversed high blood sugar in mouse models of diabetes, showing significant potential as a new diabetes treatment and opening new avenues for its application beyond mitochondrial disease.
Feb 19, 2026 · 21 articles
Relationships (7)
Yolanda Marti-Mateos ↔ HypoxyStat Unknown
Gladstone Institutes ↔ HypoxyStat Unknown
Isha Jain inventor ↔ HypoxyStat Isha Jain's lab developed the drug HypoxyStat.
Gladstone Institutes ↔ HypoxyStat Unknown
Yolanda Martí-Mateos ↔ HypoxyStat Unknown
Allan Doctor ↔ HypoxyStat Unknown
Angelo D Alessandro ↔ HypoxyStat Unknown
NEWSDESK
Track HypoxyStat live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.